Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Edwards Lifesciences Corporation (EW)

70.03   0.57 (0.82%) 09-26 14:26
Open: 69.41 Pre. Close: 69.46
High: 70.97 Low: 69.29
Volume: 2,227,339 Market Cap: 42,572(M)

Technical analysis

as of: 2023-09-26 1:48:27 PM
Short-term rate:       
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Mid-term rate:       
Target: Six months: 87.51     One year: 91.82
Support: Support1: 68.94    Support2: 57.36
Resistance: Resistance1: 74.92    Resistance2: 78.62
Pivot: 72.86
Moving Average: MA(5): 70.26     MA(20): 73.87
MA(100): 83.62     MA(250): 80.88
MACD: MACD(12,26): -2.5     Signal(9): -2.3
Stochastic oscillator: %K(14,3): 6.8     %D(3): 4
RSI: RSI(14): 28
52-week: High: 94.87  Low: 67.12
Average Vol(K): 3-Month: 3,237 (K)  10-Days: 3,099 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ EW ] has closed above bottom band by 17.9%. Bollinger Bands are 5.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 69.79 - 70.28 70.28 - 70.66
Low: 67.66 - 68.33 68.33 - 68.84
Close: 68.53 - 69.44 69.44 - 70.14

Company Description

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Headline News

Tue, 26 Sep 2023
Exclusive: Edwards Lifesciences cooperating with EU antitrust ... -

Tue, 26 Sep 2023
Should You Hold Edwards Lifesciences Corp (EW) in Medical Devices Industry? - InvestorsObserver

Tue, 26 Sep 2023
Oppenheimer Upgrades Edwards Lifesciences (EW) - Nasdaq

Mon, 25 Sep 2023
Oak Harvest Investment Services Makes New Investment in ... - MarketBeat

Sun, 24 Sep 2023
Pacer Advisors Inc. Grows Stock Holdings in Edwards Lifesciences ... - MarketBeat

Tue, 19 Sep 2023
FSM Wealth Advisors LLC Takes Position in Edwards Lifesciences ... - MarketBeat

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. 608 (M)
Shares Float 602 (M)
% Held by Insiders 0.8 (%)
% Held by Institutions 85.5 (%)
Shares Short 10,750 (K)
Shares Short P.Month 9,470 (K)

Stock Financials

EPS 2.2
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 10.48
Profit Margin (%) 24.5
Operating Margin (%) 28.4
Return on Assets (ttm) 11.5
Return on Equity (ttm) 22.3
Qtrly Rev. Growth 11.3
Gross Profit (p.s.) 7.07
Sales Per Share 9.31
EBITDA (p.s.) 2.87
Qtrly Earnings Growth -23.2
Operating Cash Flow 940 (M)
Levered Free Cash Flow 809 (M)

Stock Valuations

PE Ratio 31.84
PEG Ratio 2.9
Price to Book value 6.67
Price to Sales 7.52
Price to Cash Flow 45.28

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.